Instil Bio, Inc. Lessee, Operating Lease, Liability, to be Paid, Year One
Instil Bio, Inc. (TIL) had Lessee, Operating Lease, Liability, to be Paid, Year One of $514.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths · last filed 2026-08-13
- 2026-06-30: Lessee, Operating Lease, Liability, to be Paid, Year One $514.00K.
- 2025-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One $400.00K.
- 2025-09-30: Lessee, Operating Lease, Liability, to be Paid, Year One $170.00K.
- 2025-06-30: Lessee, Operating Lease, Liability, to be Paid, Year One $171.00K.
| Period end | Lessee, Operating Lease, Liability, to be Paid, Year One | Lessee, Operating Lease, Liability, to be Paid, Year One as first filed |
|---|---|---|
| 2026-06-30 | $514.00K 10-Q · filed 2026-08-13 | |
| 2025-12-31 | $400.00K 10-K · filed 2026-03-27 | |
| 2025-09-30 | $170.00K 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $171.00K 10-Q · filed 2025-08-13 | |
| 2025-03-31 | $169.00K 10-Q · filed 2025-05-13 | |
| 2024-12-31 | $1.82M 10-K · filed 2025-03-04 | |
| 2024-09-30 | $1.59M 10-Q · filed 2024-11-13 | |
| 2024-06-30 | $1.82M 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $1.82M 10-Q · filed 2024-05-10 | |
| 2023-09-30 | $1.98M 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $1.99M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $2.09M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $2.42M 10-Q · filed 2023-05-11 | $2.81M 10-K · filed 2023-03-31 |
| 2022-09-30 | $2.77M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $2.46M 10-Q · filed 2022-08-12 | |
| 2022-03-31 | $2.35M 10-Q · filed 2022-05-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |